New Methods and Technologies to Support Development of Next Generation Biotherapeutics

The Analytics Stream at the PEGS Summit Boston 2026 offers cutting-edge programs focused on advancing analytical science for next generation biotherapeutics. ML and Digital Integration in Biotherapeutic Analytics track will showcase how automation, AI, and data strategy are reshaping analytical workflows, from assay design and predictive modeling to digital twins and real-time release testing. Biophysical Methods will highlight innovations in high-throughput and miniaturized assays, mass spectrometry, and image-based tools for characterizing new modalities, with a focus on predictive modeling, developability, and solutions to formulation challenges. And Characterization for Novel Biotherapeutics will cover emerging modalities including genetic medicines, cell therapies, radiotherapies, next-generation conjugates, and oligonucleotide and peptide therapeutics, exploring both analytical strategies and regulatory considerations. Together, these programs provide a comprehensive view of the tools driving biotherapeutic innovation forward.

Conferences Include:

May 11-12

ML and Digital Integration in Biotherapeutic Analytics

May 12-13

Biophysical Methods

May 14-15

Characterization for Novel Biotherapeutics

Keynote and Features Presentations:

From Targets to Biologics: AI Powering the Next Leap in Discovery at Takeda
Yves Fomekong Nanfack, PhD, Head of AI/ML Research, Takeda

High-Throughput Small-Angle X-ray Scattering (SAXS) Approach to Predict High-Concentration Viscosity from Dilute Samples
Pin-Kuang Lai, PhD, Assistant Professor, Chemical Engineering and Materials Science, Stevens Institute of Technology

Revolutionizing Technologies for RNA Analytical Workflows: Academic versus BioPharma Strategies
Anubhav Tripathi, PhD, Professor, Engineering & Medical Sciences, Brown University

2026 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology & Beyond
• Driving Clinical Success in Antibody-Drug Conjugates

• TS: Intro to Multispecific Antibodies
• Advancing Multispecific Antibodies
• Engineering Bispecific and Multispecific Antibodies

• Emerging T Cell Engagers
• Advances in Immunotherapy
• Next-Generation Immunotherapies

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Maximizing Protein Production Workflows

• ML and Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Predicting Immunogenicity with AI/ML Tools
• TS: Bioassay Development and Analysis

• Biologics for Autoimmune Diseases
• Frontiers in Radiopharmaceutical Therapy
• Emerging Peptide Therapeutics

• ML and Digital Integration in Biotherapeutic Analytics
• Predicting Immunogenicity with AI/ML Tools
• Machine Learning for Protein Engineering